How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program

Marcello Tonelli, Sanjay Agarwal, Alan Cass, Guillermo Garcia Garcia, Vivek Jha, Sarala Naicker, Haiyan Wang, Chih-Wei Yang, Donal O'Donoghue

    Research output: Contribution to journalArticle

    Abstract

    Many countries are developing or refining national strategies for noncommunicable chronic disease (NCD) prevention and control.1 Most such strategies follow the World Health Organization (WHO) priorities for key NCDs, especially cardiovascular disease and diabetes.2 Chronic kidney disease (CKD) is both a cause and consequence of other NCDs; CKD acts as a risk multiplier for all four key WHO NCDs; CKD is associated with high health-care costs; CKD is readily identifiable; and treatment of CKD improves outcomes at a reasonable cost.3 These observations argue in favor of including CKD in national NCD programs. The purpose of this document is to outline key steps in advocating for the inclusion of CKD in national NCD strategies (termed ‘CKD advocacy’ for brevity below).
    Original languageEnglish
    Pages (from-to)1269-1274
    Number of pages6
    JournalKidney International
    Volume85
    Issue number6
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program'. Together they form a unique fingerprint.

  • Cite this

    Tonelli, M., Agarwal, S., Cass, A., Garcia Garcia, G., Jha, V., Naicker, S., Wang, H., Yang, C-W., & O'Donoghue, D. (2014). How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney International, 85(6), 1269-1274. https://doi.org/10.1038/ki.2012.488